95BPrescribed monitored medicines

95B Prescribed monitored medicines

[Regulation 95B Inserted by S.R. 2021, No. 110, Applied:17 Dec 2021] [Regulation 95B Substituted by S.R. 2022, No. 28, Applied:01 Jul 2022]

(1)  For the purposes of paragraph (b) of the definition of monitored medicines in section 3(1) of the Act, the following are prescribed to be monitored medicines:

(a) codeine (S4);

(b) dextropropoxyphene;

(c) gabapentin;

(d) olanzapine;

(e) pregabalin;

(f) quetiapine;

(g) tramadol;

(h) zolpidem;

(i) zopiclone.

(2)  For the purposes of paragraph (c) of the definition of monitored medicines in section 3(1) of the Act, substances that are in the class of substances known as benzodiazepines are prescribed to be monitored medicines.